Seaport Therapeutics, Inc.

Research Seaport Therapeutics, Inc. (SPTX) on Bullrun: market cap USD 1.19B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSPTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.19B
• Financial periodQ1 2026
• Net income-USD 25.41M
• Free cash flow-USD 20.17M

Valuation Snapshot

latest market cap is USD 1.19B.

About Seaport Therapeutics, Inc.

Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects.

Frequently asked questions

What is Seaport Therapeutics, Inc.'s market cap?

Seaport Therapeutics, Inc.'s market capitalization is USD 1.19B.

What does Seaport Therapeutics, Inc. do?

Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform.